Cross-Sector entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Cyclospora cayetanensis, the most common co-covered peer. Each carries 6 original sources on average. We currently track 1 Cross-Sector story that mention trimethoprim-sulfamethoxazole, all published on July 12, 2026.
1 verified story tracked
Last mentioned: Jul 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Cyclospora cayetanensis, the most common co-covered peer. Each carries 6 original sources on average. We currently track 1 Cross-Sector story that mention trimethoprim-sulfamethoxazole, all published on July 12, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering trimethoprim-sulfamethoxazole. Shared-story counts are live from our verified record — not editorial picks.
With 992 infections in Michigan, the cyclospora outbreak creates urgent demand for antibiotic supplies and spotlights the need for novel antiparasitic therapies, presenting both short-term and long-term opportunities for biopharma.
Source: sandiegouniontribune.com · orlandosentinel.com
